AstraZeneca PLC (AZN) vs Eli Lilly and Company (LLY)
LLY leads on 9 of 17 compared metrics, though AZN is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs LLY
growth of $100 · last 30yAZN +723.4%LLY +3454.0%LLY compounded faster
AZN LLY
AZN vs LLY: by the numbers
- •LLY is the larger company ($1.07T vs $277.22B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 40.25 P/E).
- •LLY converts more revenue to profit (34.98% vs 17.19% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 16.99% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 0.57%).
Which is better, AZN or LLY?
Metric tally: AZN 8 · LLY 9It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthLLY(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityLLY(higher ROIC)
Valuation
| Metric | AZN | LLY |
|---|---|---|
| P/E ratio | 26.92● | 40.25 |
| Forward P/E | 15.33● | 25.41 |
| P/S ratio | 4.62● | 14.05 |
| P/B ratio | 5.90● | 32.54 |
| PEG ratio | 0.14● | 0.49 |
| EV / EBITDA | 14.92● | 31.47 |
| FCF yield | 3.26%● | 1.34% |
Profitability
| Metric | AZN | LLY |
|---|---|---|
| Gross margin | 81.68% | 83.51%● |
| Operating margin | 23.69% | 45.87%● |
| Net margin | 17.19% | 34.98%● |
| ROE | 21.95% | 81.01%● |
| ROIC | 13.03% | 30.20%● |
Dividends
| Metric | AZN | LLY |
|---|---|---|
| Dividend yield | 1.79%● | 0.57% |
| Payout ratio | 48.48% | 28.09% |
Growth (annualized)
| Metric | AZN | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 23.17%● |
| EPS CAGR (5Y) | 22.02% | 28.88%● |
| FCF CAGR (5Y) | 18.52% | 19.54%● |
| Total return CAGR (5Y) | 11.03% | 39.57%● |
Frequently asked
- Which is better, AZN or LLY?
- It depends on your goal. value: AZN (lower P/E); growth: LLY (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: LLY (higher ROIC). Across all compared metrics, LLY leads 9 to 8.
- Is AZN or LLY cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and LLY at 40.25.
- Which has grown faster, AZN or LLY?
- Over the past five years, LLY grew revenue faster — AZN at a 16.99% CAGR versus LLY at 23.17%.
- Does AZN or LLY pay a bigger dividend?
- AZN yields 1.79% and LLY yields 0.57% based on trailing dividends and the latest price.
- Is AZN or LLY more profitable?
- LLY runs the higher net margin — AZN at 17.19% versus LLY at 34.98%.
- Which has been the better investment, AZN or LLY?
- Over the past 10-year, LLY delivered the higher annualized total return — AZN at 15.77% versus LLY at 33.50%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioEli Lilly and P/E ratioAstraZeneca dividend yieldEli Lilly and dividend yieldAstraZeneca ROEEli Lilly and ROEAstraZeneca operating marginEli Lilly and operating marginAstraZeneca revenue growthEli Lilly and revenue growthAstraZeneca free cash flowEli Lilly and free cash flow
AstraZeneca & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.